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STATE ESTIMATION OF GLUCOSE AND INSULIN DYNAMICS

MORGAN MILLER

ABSTRACT
Process simulation and state estimation have very important applications in
chemical engineering as well as the biomedical field. Diabetes is a rapidly growing disease
in the United States with 29 million people already diagnosed. The estimation of glucose
and insulin concentration in patients is necessary in order to effectively treat diabetes. The
Bergman Minimal Model is a popular process model that is used to simulate glucose and
insulin dynamics. A simulation of this model was created based on estimated parameters
for the model from historical data. This thesis investigated the estimation of glucose
concentration, insulin concentration, and effect of active insulin using the extended Kalman
filter, unscented Kalman filter, ensemble Kalman filter, and sequential Monte Carlo Particle
filter. The performance of the filters was compared using root mean squared error. The
filters were studied for the cases of good filter initialization, poor filter initialization, plantmodel mismatch, increased measurement noise, and multiple glucose ingestions.
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R
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α

tuning parameter

β

tuning parameter

κ

tuning parameter

λ

tuning parameter
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insulin responsivity
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CHAPTER I
INTRODUCTION

Process simulation allows for the testing of experiments that would ordinarily be
impractical to be performed physically as a result of financial, safety, or legal constraints.
Instead of a physical experiment, a model is developed for the process and tested using
computer simulation. Most variables that are desired to be known about a process cannot
be measured directly and are correlated to other measurements from sensors such as
current or voltage. The methods and techniques for state estimation have existed for
several decades but have gained recent interest in the chemical engineering field. This is
due to the need of discrete analytical models to solve engineering problems where
accurate theoretical models either do not exist or cannot be solved practically [1].
Measurements in a chemical process are subject to errors and noise to the point where the
laws of conservation of mass and energy are not observed from these noisy
measurements [2]. This is a major problem that can affect the monitoring and control of a
process [3]. Measurements need to be filtered to reduce the impact of the noise in order
to have a better estimate for the true state of a process. In the area of chemical process
control, state estimation can be applied to estimate state variables in distillation columns,
biomedical devices, or continuously stirred tank reactors.
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A main area of interest in state estimation are biomedical applications. One of
these biomedical applications is the estimation of blood glucose and insulin dynamics due
to prevalence of diabetes in the population.

1.1

Diabetes

Diabetes is a rapidly growing disease in the United States. 29 million people in
the United States are diabetic and 86 million people are pre-diabetic, which means they
are very likely to become diabetic unless radical changes are made to their diet and
exercise routine [4]. The combined amount of people that are diabetic or pre-diabetic
accounts for nearly one third of the population in the United States. In type 1 diabetes, the
pancreas cannot produce enough insulin to control the glucose concentration in the blood
stream [4]. In type 2 diabetes, the body has become resistant to the insulin that is
produced by the pancreas [4]. In both cases of the disease, the body is unable to
effectively regulate the glucose concentration in the blood. This can have serious medical
consequences. If the glucose concentrations in the blood are too high over long periods of
time, there can be damage to the eyes including blindness, damage to the kidneys, nerve
damage, heart disease can result, and the amputation of a limb may be required [5].
One of the techniques that is used for diagnosing diabetes is the glucose tolerance
test. Patients fast for at least 8 hours before the test and have a blood sample taken
initially. This sample represents the fasting or basal glucose concentration. This can be
thought of as a steady state glucose concentration that the body always returns to after a
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meal. The patients are then given a concentrated sugar solution or an injection of glucose
and their blood is drawn at pre-determined intervals over a period of approximately 3
hours [6]. Table 1 below summarizes the typical ranges of concentrations for individuals
who are healthy, pre-diabetic, or diabetic.

Normal
PreDiabetic
Diabetic

Fasting
(mg/dL)
80-100

Immediately after meal (mg/dL)
170-200

2-3 hours after eating
(mg/dL)
120-140

101-125
>125

190-230
220-300

140-160
>200

Table I: Typical glucose concentrations for normal, pre-diabetic, and diabetic
patients [7]

1.2

Control of Diabetes

The most common treatments for diabetes involve the injection of insulin through
needles or insulin pumps. Insulin injections are given at predetermined times throughout
the day. Insulin pumps deliver a continuous dosage throughout the day known as the
basal dosage which is determined by a physician. At meal times, the dosage is changed to
a bolus dosage which is higher than the basal dosage since it needs to compensate for the
increased glucose levels in the blood as a result of the meal. These dosages are based on a
“guess” of the proper insulin dosage that would respond to what the glucose
concentrations will rise to and is adjusted by the patient based on the resulting glucose
measurements from either a continuous glucose monitor or a glucose test strip. Insulin
concentrations cannot be measured in a nonclinical setting. A glucose test strip involves
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drawing a small sample of blood from the fingertip. A continuous glucose monitor
samples interstitial tissue fluid from an electrode implanted underneath the skin [8].

Figure 1: Continuous glucose monitor illustration [8]

While there are insulin pumps available on the market that have been coupled with
continuous glucose monitors, they do not function as feedback process controllers [9].
Rather, the insulin pump takes action only when the glucose concentration is too low or
too high to avoid periods of hypoglycemia or hyperglycemia. These conditions can result
in confusion, falls, seizures, coma, or death [10]. This is not an optimal design since the
insulin dosage being provided to the patient may not accurately reflect the actual dosage
that is required to reach their normal glucose levels which could result in frequent
oscillations in glucose concentration along with wasted insulin.
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1.3

Motivation

In order to ensure the proper dosage of insulin is being administered at all times, a
feedback loop needs to be created where measurements from a glucose monitor are used
to estimate the true glucose and insulin concentrations. This feedback loop process
controller can replace the function of the pancreas in a diabetic and may be referred to as
an artificial pancreas.

1.4

Scope of the Thesis

This thesis investigates the use of the extended Kalman filter, unscented Kalman
filter, ensemble Kalman filter, and particle filter to estimate the glucose concentration,
insulin concentration, and effect of active insulin in the human body.
The performance of the extended Kalman filter, unscented Kalman filter,
ensemble Kalman filter, and particle filter is investigated for the following cases:


Good filter initialization: The performance of the filters is compared when the
initial estimate of the state is very close to the actual state. This is done for cases
of both high and low confidence in the initial estimate which is reflected in
adjusting the value for the initial covariance matrix for the filter.



Poor filter initialization: The performance of the filters is compared for the
scenario when the initial estimate of the state is distant from the actual state. This
is also done for the cases of both high and low confidence in the initial estimate
which is reflected in the initial covariance matrix.
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Plant-Model mismatch: The performance of the filters is compared for the
scenario where the model for the system used in the state estimator does not
accurately describe the true state. There are 2 cases of plant-model mismatch. The
1st case is where the value for insulin sensitivity for the estimator is not equal to
the actual insulin sensitivity of the patient. The 2nd case where the system is
changed to an elderly patient while the estimator uses the model parameter values
for a normal patient.



Large measurement noise: The performance is compared for 3 levels of signal
noise from the glucose measurement.



Multiple glucose ingestions: The performance of the filters is compared for the
scenario where a 2nd glucose ingestion occurs 60 minutes into the simulation. The
filters are compared for the case when the filter knows the ingestion has taken
place and when the filter does not know the ingestion has taken place.

1.5

Organization of the Thesis

This thesis has been organized in the following manner. The mathematical model
for glucose and insulin dynamics is discussed in Chapter 2. Chapter 3 explains the
different types of filters used for state estimation. This includes the different variants of
the Kalman filter along with the Monte Carlo based particle filter. The results of the
simulation study and comparison of the filters are presented in Chapter 4. Chapter 5
presents the conclusions and provides the direction for future work.
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CHAPTER II
GLUCOSE AND INSULIN MODEL

In 1986, Richard Bergman and Giovanni Pacini developed a model to describe
glucose and insulin dynamics known as the Minimal Model [11]. The Minimal Model
can be used to describe the glucose and insulin dynamics of healthy people not affected
by diabetes as well as diabetics. This is accomplished by adjusting the parameter values
introduced in the model to fit recorded patient data. Since the Minimal Model was first
developed, there have been over 100 technical reports published regarding the model
[12]. The accuracy of the model was tested by performing intravenous glucose tolerance
tests on humans. The patients were given an initial injection of 0.3 g/kg of glucose. This
means that the dosages were normalized to account for the different weights of patients in
the study. Their glucose and insulin levels were then measured for approximately 3 hours
to obtain information on the dynamic behavior of the glucose and insulin system.
Frequent samples of blood were drawn from the patients to obtain measurements of the
glucose and insulin concentrations. This was done in order to establish the shape of the
concentration profiles over time. The measured data along with the model that was fit to
the data can be seen in Figure 2. The basal glucose and insulin concentrations are plotted
as dashed lines. It can be seen that after the initial peak from the glucose injection, the
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levels undershoot the basal levels and then oscillate around the basal levels. The insulin
concentration is reported in units of micro units per milliliter which is a standardized unit
of measure in the medical field.

Figure 2: Measured glucose and insulin concentrations vs. time [11]
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The model assumed that glucose returns to its basal concentration due to the effect of
glucose to regulate its concentration by itself and due to the effect of insulin. Figure 3
shows a physiological representation of the model proposed by Bergman.

Figure 3: Physiological representation for glucose and insulin dynamics [12]

The glucose concentration is represented by the level in the tank in figure 3. The level
can change due to production by the liver or utilization by the body including the central
nervous system and muscles. The pancreas responds to the glucose level by producing
insulin which is transported from the bloodstream to the “remote” compartment which is
interstitial tissue where it can increase the glucose uptake by the muscles or fat tissue or
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reduce the glucose production by the liver. After a meal or an injection of glucose, the
glucose level rises which causes a response by the pancreas. The pancreas produces
insulin which is transferred into the interstitial tissue where it acts to return the glucose to
the basal level. This creates a biological feedback loop. An analogous process control
block diagram for the Minimal Model can be seen in Figure 4.

Figure 4: Control system analog for glucose and insulin kinetics [13]
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G(t) and I(t) are the glucose and insulin concentrations as functions of time respectively.
Gb and Ib are the basal or steady state glucose and insulin concentrations respectively.
X(t) is not an actual physiological measurement quantity but the effect of active insulin or
what is sometimes referred to as the effective insulin activity in min-1. The insulin
activity quantity accounts for the insulin having to travel from the bloodstream into the
interstitial tissue to respond to the glucose level. The pancreas in the glucose and insulin
system basically functions as a process controller. Glucose enters the plasma
compartment at a rate proportional to the difference between the actual and basal
concentrations. Glucose exits the plasma compartment at a rate proportional to the
activity of insulin in the interstitial tissue. Insulin enters the plasma compartment at a rate
proportional to the insulin responsivity by the pancreas multiplied by the time and exits at
a rate proportional to the amount of insulin in the plasma compartment.
The equations for the Minimal Model are derived from unsteady state material
balances in the body. The general unsteady state material balance is as follows:
𝐼𝑛 − 𝑂𝑢𝑡 + 𝐺𝑒𝑛𝑒𝑟𝑎𝑡𝑖𝑜𝑛 − 𝐶𝑜𝑛𝑠𝑢𝑚𝑝𝑡𝑖𝑜𝑛 = 𝐴𝑐𝑐𝑢𝑚𝑢𝑙𝑎𝑡𝑖𝑜𝑛
(2.1)
The unsteady state material balances for glucose and insulin are taken from the reference
and shown in the following equations below [11]:
𝑘1 (𝐺𝑏 − 𝐺) − 𝑋𝐺 =

𝑑𝐺
𝑑𝑡
(2.2)

Where k1 is the glucose effectiveness in min-1 which may also be written as SG, Gb is the
basal glucose concentration in

𝑚𝑔

, G is the glucose concentration in
𝑑𝐿

𝑚𝑔
𝑑𝐿

, and X is the

effect of active insulin also known as insulin activity in interstitial tissue in min-1.
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𝑘3 (

𝑘2
𝑑𝑋
(𝐼 − 𝐼𝑏 ) − 𝑋) =
𝑘3
𝑑𝑡
(2.3)

Where k2 is the weighted external insulin input in min-1, k3 is the insulin clearance in min1

, I is the insulin concentration in

𝑚𝑖𝑐𝑟𝑜𝑈
𝑚𝐿

, Ib is the basal insulin concentration in

𝑚𝑖𝑐𝑟𝑜𝑈
𝑚𝐿

,

X is the insulin activity in min-1, and the ratio of k2 to k3 is the insulin sensitivity (SI). The
insulin sensitivity reflects how effective the insulin is at returning to the basal
concentration. Diabetics would have lower insulin sensitivities since they have impaired
glucose tolerance. Equation 2.3 describes the dynamics of the transport of insulin from
the blood to interstitial fluid. The final equation in the model describes the change in
insulin concentration in the blood over time.
𝛾(𝐺 − 𝐺𝑏 )𝑡 − 𝑘(𝐼 − 𝐼𝑏 ) =

𝑑𝐼
𝑑𝑡
(2.4)

Where γ is the insulin responsivity by the pancreas in min-2, G is the glucose
concentration in

𝑚𝑔
𝑑𝐿

, Gb is the basal glucose concentration in

the insulin decay rate, I is the insulin concentration in
concentration in

𝑚𝑖𝑐𝑟𝑜𝑈
𝑚𝐿

𝑚𝑔
𝑑𝐿

𝑚𝑖𝑐𝑟𝑜𝑈
𝑚𝐿

, t is the time in min, k is

, and Ib is the basal insulin

. The material balances result in 3 coupled differential equations

(2.2, 2.3, and 2.4) which form the Minimal Model.
Since the original Minimal Model has been proposed, there have been several
proposed modifications to the model by other researchers. An example of this is a
modification of the model to include the effect of physical exercise on insulin sensitivity
and glucose effectiveness [14]. This is done by creating a more complex system that
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result in more than 3 coupled differential equations. Other modifications that have been
proposed include the addition of parameters to account for genetic risk factors and
obesity [15].

Matlab Implementation

The glucose insulin system was generated by simulating the original Bergman
Minimal Model in MATLAB. The 3 coupled differential equations were solved using the
MATLAB differential equation solver function ODE15s. This is a differential equation
solver for stiff functions which was chosen after the standard differential equation solver
ODE45 function failed to solve the system of equations in a timely manner. The system
was simulated for 180 minutes with glucose measurements taken at every minute.

14

CHAPTER III
STATE ESTIMATION

3.1

Kalman Filter

There are several types of state estimators that have been introduced over the
years. One popular type is the Kalman filter. The Kalman filter is a recursive data
processing algorithm that combines all available measurement data, plus prior knowledge
about the system and measurement devices to produce an estimate of the desired
variables. The Kalman filter can be applied when the state equations are linear and there
is a Gaussian distribution for the probability density function of the state for all of the
time steps.
The following is a general linear system that the Kalman filter could be applied to
which includes equations for the state as well as the measurement.
𝑥𝑘 = 𝐴𝑥𝑘−1 + 𝑤𝑘
(3.1)
Where 𝑥𝑘 is the state of the system at times step k, A is a constant, 𝑥𝑘−1 is the state at
time step k-1, and 𝑤𝑘 is the process noise.
𝑦𝑘 = 𝐶𝑥𝑘−1 + 𝑣𝑘
(3.2)
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Where 𝑦𝑘 is the measurement at times step k, C is a constant, 𝑥𝑘−1 is the state at time
step k-1, and 𝑣𝑘 is the measurement noise.

3.2

Extended Kalman Filter

For non-linear systems, other state estimators are required. The extended Kalman
filter attempts to apply the Kalman filter to nonlinear systems by linearizing the system
and measurement equations for each time step. This is done through the use of a Taylor
expansion for each time step. This results in a Jacobian matrix of partial derivatives.
1+
𝜕𝑓
𝐹=
=[
𝜕𝑥

(−𝑆𝐺 − 𝑋) ∗ 𝑑𝑡
0
𝑘 ∗ 𝛾 ∗ 𝑑𝑡

−𝐺 ∗ 𝑑𝑡
1 − 𝑘3 ∗ 𝑑𝑡
0

0
𝑆𝐼 ∗ 𝑘3 ∗ 𝑑𝑡]
1 − 𝑘1 ∗ 𝑑𝑡
(3.3)

𝐻=

𝜕ℎ
= [1
𝜕𝑥

0 0]
(3.4)

F and H are the Jacobian matrices of the state and measurement functions respectively.
The Kalman gain (Kk), covariance (Pk) and estimate (𝑥̂𝑘 ) are updated as shown in
equations 3.5, 3.6, and 3.7.
𝐾𝑘 = 𝑃𝑘 𝐻𝑘𝑇 (𝐻𝑘 𝑃𝑘 𝐻𝑘𝑇 + 𝑅)−1
(3.5)
𝑃𝑘 = 𝑃𝑘−1 − 𝐾𝑘 𝐻𝑘 𝑃𝑘−1
(3.6)

𝑥̂𝑘 = 𝑥̂𝑘−1 + 𝐾𝑘 (𝑦𝑘 − 𝐻𝑥̂𝑘 )
16

(3.7)
Where 𝑥̂𝑘 is the estimate state of the system at times step k, R is the system noise
covariance matrix, 𝑥̂𝑘−1 is the state at time step k-1, Kk is the Kalman gain at time step k,
𝑃𝑘 is the system covariance matrix at time step k, 𝑦𝑘 is the measurement at times step k,
H is the Jacobian matrix of the measurement function. The reason matrix transposes and
inverses are used in equation 3.5 is due to the behavior of Gaussian systems as well in
order to obtain a feasible solution with the proper dimensions.
A drawback of the extended Kalman filter is that it requires the system and
measurement functions to be differentiable and knowledge of what the derivatives of
those function are. Some functions that are nonlinear may also not be linearized well by
only a first order Taylor expansion.

3.3

Unscented Kalman Filter

The unscented Kalman filter takes another approach to apply the Kalman filter to
nonlinear systems. The unscented Kalman filter involves a method of statistical
linearization by deterministically sampling 2n+1 “sigma points” where n is the number of
states that represent the system. The points that are sampled represent the current mean
and the standard deviation from both sides of the mean. The points are fed through the
system equation. As a result, the distribution of the sigma points is no longer symmetric.
Sigma points are re-generated symmetrically by calculating the new weighted mean and
covariance and choosing new points accordingly. A graphical representation of the sigma
points can be seen in figure 4 from the reference [16].
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Figure 4: Symmetric sigma points for the Minimal Model system [16]

The dots connected by the solid line represent the initially symmetric sigma points while
the dots connected by the dashed lines show a possible distribution that can result after
the sigma points are passed through the nonlinear system. The sigma points are
regenerated symmetrically using the following equations.
𝑥0 = 𝑥̅
(3.8)
Where 𝑥0 is the central point which is taken from the weighted mean of the sigma points
(𝑥̅ ). The remaining sigma points are generated based off of the standard deviation from
the mean. In the case of model used in this thesis, there are 3 sigma points on the positive
side of the mean and 3 sigma points on the negative side of the mean. This is shown in
equations 3.9 and 3.10.
𝑥𝑖 = 𝑥̅ + (√(𝑛 + 𝜆)𝑃𝑥𝑥 )

𝑖
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(3.9)
𝑥𝑖 = 𝑥̅ − (√(𝑛 + 𝜆)𝑃𝑥𝑥 )

𝑖

(3.10)
The weighted mean for the estimate of the state of the system is calculated as follows:

2𝑛+1

𝑥̅ 𝑘 = ∑ 𝑊𝑖 𝑥𝑘,𝑖
𝑖=0

(3.11)

The weights for the mean and covariance for the central sigma points are assigned using
the following equations:
(0)

𝑊𝑎

=

𝜆
𝑛+𝜆
(3.12)

(0)

𝑊𝑐

=

𝜆
+ 1 − 𝛼2 + 𝛽
𝑛+𝜆
(3.13)

(0)

Where 𝑊𝑎

(0)

is the weight of the central sigma point for the mean and 𝑊𝑐

is the weight

of the central sigma point for covariance. The weights for the mean and covariance for
the rest of the sigma points are assigned using the following equations:

𝑊𝑎𝑖 = 𝑊𝑐𝑖 =

1
2(𝑛 + 𝜆)
(3.14)
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𝜆 = 𝛼 2 (𝑛 + 𝜅)
(3.15)
Where n is the number of sigma points, λ is a function of the tuning parameters α, β, and
κ which have typical values of α=0.5, β=2, and κ=3-n [17]. The values for these
parameters can be adjusted to “tune” the filter to the system with an unbiased estimate as
long as the sum of the resulting weights is equal to 1.
The following equations are used to update the estimate of the state and the covariance:
𝑁

𝑃𝑥𝑦

1
=
∑[𝑥𝑖 − 𝑥̅ ] 𝑊𝑖 [ℎ(𝑥𝑖 ) − ℎ(𝑥̅ )]𝑇
𝑁−1
𝑖=1

(3.16)
𝑁

𝑃𝑦𝑦

1
=
∑[ℎ(𝑥𝑖 ) − ℎ(𝑥̅ )] 𝑊𝑖 [ℎ(𝑥𝑖 ) − ℎ(𝑥̅ )]𝑇 + 𝑅
𝑁−1
𝑖=1

(3.17)
−1
𝐾 = 𝑃𝑥𝑦 𝑃𝑦𝑦

(3.18)
𝑥̂𝑘 = 𝑥̂𝑘−1 + 𝐾(𝑦𝑘 − ℎ(𝑥̂𝑘 ))
(3.19)
An advantage of the unscented Kalman filter is that the system and measurement
equations do not need to be linearized at each time step through Taylor expansions. This
means there is no longer the need to calculate Jacobians as is the case in the extended
Kalman filter.
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3.4

Ensemble Kalman Filter

The ensemble Kalman filter is another way to utilize the Kalman filter for
nonlinear systems. Instead of representing the mean and covariance of the state through
deterministically chosen sigma points like the unscented Kalman filter, the ensemble
Kalman filter utilizes a more stochastic process. The ensemble Kalman filter involves
sampling a large number of random points to obtain the mean and covariance. In this
thesis, 100 points which each had a value for the glucose concentration, insulin
concentration, and effect of active insulin were used for the ensemble Kalman filter. The
initial distribution of the points is assumed to be Gaussian. After the initial time step, the
points are fed through the nonlinear state equation and their distribution becomes nonGaussian. In this filter, the sample mean and sample covariance are used instead of some
type of weighted mean and covariance.
𝑁

𝑃𝑥𝑦

1
=
∑[𝑥𝑖 − 𝑥̅ ] [ℎ(𝑥𝑖 ) − ℎ(𝑥̅ )]𝑇
𝑁−1
𝑖=1

(3.20)

𝑁

𝑃𝑦𝑦

1
=
∑[ℎ(𝑥𝑖 ) − ℎ(𝑥̅ )] [ℎ(𝑥𝑖 ) − ℎ(𝑥̅ )]𝑇 + 𝑅
𝑁−1
𝑖=1

(3.21)

−1
𝐾 = 𝑃𝑥𝑦 𝑃𝑦𝑦

(3.22)
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𝑥̂𝑘 = 𝑥̂𝑘−1 + 𝐾(𝑦𝑘 − ℎ(𝑥̂𝑘 ))
(3.23)
𝑁

1
𝑃𝑥𝑥 =
∑[𝑥𝑖 − 𝑥̅ ] [𝑥𝑖 − 𝑥̅ ]𝑇
𝑁−1
𝑖=1

(3.24)
The ensemble Kalman filter does not require the Gaussian assumption that is made for
the propagation of sigma points in the unscented Kalman filter. A shortcoming of the
ensemble Kalman filter is that all of the particles are assigned equal weights regardless of
what their distribution [18].

3.5

Particle Filter

The last state estimator discussed in this thesis is the Monte Carlo based particle
filter which was first proposed by Gordon et al [19]. In the particle filter, the assumptions
of a Gaussian distribution and linear system are no longer required. Since there is no
readily available formula for the probability density function of non-linear and nonGaussian processes, the use of Monte Carlo simulation is required. Monte Carlo
simulation involves drawing a large number of random samples to estimate integrals or
areas. In the case of the particle filter, it is used to estimate the area of the probability
density function.
The conditioned probability density for the particle filter is based off of Bayes
rule and is as follows:
𝑝𝑜𝑠𝑡𝑒𝑟𝑖𝑜𝑟 =

𝑙𝑖𝑘𝑒𝑙𝑖ℎ𝑜𝑜𝑑 × 𝑝𝑟𝑖𝑜𝑟 𝑝(𝑦1 |𝑥1 )𝑝(𝑥1 |𝑦0 )
=
𝑒𝑣𝑖𝑑𝑒𝑛𝑐𝑒
𝑝(𝑦1 )
22

(3.25)
Where 𝑝(𝑦1 |𝑥1 ) is the probability of 𝑦1 conditioned on 𝑥1 , and 𝑝(𝑥1 |𝑦0 ) is the
probability of 𝑥1 conditioned on 𝑦0 , and 𝑝(𝑦1 ) is a normalizing constant.
The particle filter estimates the state of the system by using a weighted estimate.
In order to determine the weights of the particles, the following equation was used.
𝑊𝑒𝑖𝑔ℎ𝑡 =

1
√2𝜋𝑅

𝑒𝑥𝑝 (−

(𝑦 − ℎ(𝑥))2
)
2𝑅
(3.26)

Where R is the sensor noise variance, x is the state, y is the measurement, and h(x) is the
measurement function of x. In this equation, the transition density was used as the
importance density. This was done out of computational ease however there are other
techniques for calculating the importance density.
The state was estimated by taking a weighted average of the particles at each time
step in the simulation as shown in equation 3.27 below:
𝑋𝑒𝑠𝑡𝑖𝑚𝑎𝑡𝑒 = ∑

𝑥 × 𝑊𝑒𝑖𝑔ℎ𝑡
∑ 𝑊𝑒𝑖𝑔ℎ𝑡
(3.27)

Where 𝑋𝑒𝑠𝑡𝑖𝑚𝑎𝑡𝑒 is the estimated value of the state, x is the vector of particles created for
the simulation, and the weight is the vector of weights for each particle which was
normalized. This was performed for each time step to estimate the state of the process.
A resampling step was added to the particle filter algorithm. One reason
resampling is performed is to prevent a condition known as degeneracy. This is where
after a large number of time steps, only one particle has significant weight [20]. This
means that computational effort is wasted on particles with negligible weight while only
23

one particle determines the estimate of the state. In the resampling step which occurs at
every time step, particles with low weights were eliminated while particles with high
weights were duplicated. There are several types of resampling methods that vary in
computational efficiency which include multinomial resampling, stratified resampling,
systematic resampling, and residual resampling [21]. In this case, residual resampling
was chosen. More information about the algorithm can be found from the reference [21].
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CHAPTER IV
SIMULATION STUDY

The application of a process controller to function as an artificial pancreas will
have to respond to the changes to the glucose insulin system during meal time. The
Minimal Model that was described in chapter 2 was used as the simulation of the true
state of glucose and insulin dynamics using the ODE15s function to solve the differential
equations. The parameters used in the differential equations are taken from the reference
and summarized in table II below [11].
SG (min-1)

0.03082

SI min-1(microU/mL)-1

5.07E-04

k1 (min-1)

0.3

k3 (min-1)

0.02093

Gamma min-2(microU/mL)(mg/dL)-1

0.003349

Gb (mg/dL)
89.5
Ib (microU/dL)
7.3
Table II: Minimal model parameters
Glucose measurements were also generated by adding random noise to the true
glucose concentration. Figures 5, 6, and 7 show the system under normal circumstances
which was used for the good filter initialization and poor filter initialization case studies.
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Figure 5: Glucose concentration vs. time

Figure 6: Effect of active insulin vs. time
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Figure 7: Insulin concentration vs. time

In order to evaluate the performance of the filters, the root mean squared error
(RMSE) was computed as shown in the following equation.
𝑘

1
𝑅𝑀𝑆𝐸 = √ ∑(𝑋𝑡 − 𝑋)2
𝑘
𝑖=0

(4.1)
Where k is the number of time steps, Xt is the true value of the state, and X is the state
estimate. The comparison of the RMSE of the filters is given as an empirical observation
and is not meant as an ultimate comparison as which filter is the absolute best. This is
because of the selection of tuning parameters, number of samples generated, and
selection of importance density will vary among other programmers and impact the
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results of the same type of filter. The computational times were calculated for illustrative
purposes as no attempt was made to optimize the coded algorithm of the filters for speed.
Another reason to calculate the computational times was to see if the filters could be
implemented in real time even if they were not optimized for speed. The figures
presented in each case study are for realizations of filter performance that had a RMSE
close to the average and are presented for illustrative purposes.

4.1

Good Filter Initialization

The following results are for the case of good filter initialization where the initial
estimate and state covariance are as follows:
𝑥0 = [289 1 × 10−7 406]
22
𝑃0 = [ 0
0

0
2
1 × 10−3
0

0
0]
22
(4.2)

The estimates from all 4 filters can be seen in figures 8, 9, and 10.
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Figure 8: Good filter initialization, high confidence, glucose concentration vs. time

Figure 9: Good filter initialization, high confidence, effect of active insulin vs. time
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Figure 10: Good filter initialization, high confidence, insulin concentration vs. time

The results of the filters are summarized in table III below. It was observed that the
unscented Kalman filter had the lowest RMSE for all of the states.
EKF
UKF
EnKF
PF
0.0189
6.0395
111.275 101.9108
1.0496
0.5453
1.8381
1.1954
12.2368
0.3919
0.4794
0.6703

CPU time (s)
RMSE: Glucose (mg/dL)
RMSE: Insulin (micro U/mL)
RMSE: Effect of Active Insulin
(1/min)
0.0024 5.86E-05
1.24E-04 3.27E-04
Table III: Good filter initialization, high confidence filter performance

A 2nd case was studied where the initial estimate remains the same as before but there is
low confidence in the estimate. This is reflected in changing the value for the initial
covariance matrix which was as follows:
30

40
𝑃0 = [ 0
0

0
1 × 10−8
0

0
0]
40
(4.3)

The new covariance is 10 times the covariance for high confidence. The estimates from
all 4 filters for this case can be seen in figures 11, 12, and 13 below.

Figure 11: Good filter initialization, low confidence, glucose concentration vs. time
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Figure 12: Good filter initialization, low confidence, effect of active insulin vs. time

Figure 13: Good filter initialization, low confidence, insulin concentration vs. time
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The results of the filters are summarized in table IV below. The RMSE increased slightly
compared to the previous case of good filter initialization and high confidence. The
unscented Kalman filter still had the lowest RMSE.
EKF
UKF
EnKF
PF
0.0194
6.058 117.736
102.92
1.0613
0.5258
2.0562
1.822
12.2351
0.3847
0.4852
0.6931

CPU time (s)
RMSE: Glucose (mg/dL)
RMSE: Insulin (micro U/mL)
RMSE: Effect of Active Insulin
(1/min)
0.0024 5.51E-05 1.15E-04 3.27E-04
Table IV: Good filter initialization, low confidence

4.2

Poor Filter Initialization

The following results are for the case of poor filter initialization where the initial
estimate and state covariance are as follows:
𝑥0 = [385 1.33 × 10−7 541]
22
𝑃0 = [ 0
0

0
2
1 × 10−3
0

0
0]
22
(4.4)

The initial estimate is 33% higher than the estimate for good filter initialization. The
initial covariance matrix was unchanged which placed high confidence in this poor initial
estimate. The estimates from all 4 filters can be seen in figures 14, 15, and 16 below.
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Figure 14: Poor filter initialization, high confidence, glucose concentration vs. time

Figure 15: Poor filter initialization, high confidence, effect of active insulin vs. time
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Figure 16: Poor filter initialization, high confidence, insulin concentration vs. time

The results of the filters are summarized in table V below. The extended Kalman filter
had the lowest RMSE. In general, the filters had a higher RMSE than the case of good
filter initialization which is probably since they took longer to converge to the true states.

CPU time (s)
RMSE: Glucose (mg/dL)
RMSE: Insulin (micro U/mL)

EKF
UKF
EnKF
PF
0.0189
6.1083
108.3806 101.927
6.238
22.5345
12.5763 22.2365
2.2904
15.838
15.4067 15.7399

RMSE: Effect of Active Insulin
(1/min)
3.71E-04
2.30E-03
1.80E-03 2.40E-03
Table V: Poor filter initialization, high confidence
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The case of poor filter initialization was then repeated but with low confidence in the
initial estimate. This means that the estimator will place less trust in the initial poor
estimate. The new initial estimate and covariance are shown below.
𝑥0 = [385 1.33 × 10−7 541]
40
𝑃0 = [ 0
0

0
1 × 10−8
0

0
0]
40
(4.5)

The results from the 4 filters are shown in figures 17, 18, and 19 below.

Figure 17: Poor filter initialization, low confidence, glucose concentration vs. time
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Figure 18: Poor filter initialization, low confidence, effect of active insulin vs. time

Figure 19: Poor filter initialization, low confidence, insulin concentration vs. time
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The results of the filters are summarized in table VI below. The extended Kalman filter
had the lowest RMSE. In general, the RMSE was lower than the case of poor filter
initialization and high confidence.

CPU time (s)
RMSE: Glucose (mg/dL)
RMSE: Insulin (micro U/mL)

EKF
UKF
EnKF
PF
0.0161
5.7939
114.4744 90.8206
1.0682
22.5478
8.1905 19.7673
2.3299
15.8395
15.3371 15.7338

RMSE: Effect of Active Insulin
(1/min)
2.72E-04
2.30E-03
1.50E-03 2.40E-03
Table VI: Poor filter initialization, low confidence

4.3

Plant-Model Mismatch

The next case study was that of plant-model mismatch where the system equation
used by the estimator does not accurately describe the true system. The first case of this is
where the insulin sensitivity parameter for the estimator is 33.2% higher than the actual
sensitivity. This was chosen since it reflects the upper confidence interval for insulin
sensitivity reported from the reference [11]. This is a likely that can arise from the results
of a glucose tolerance test. The initial state estimate and covariance were the same from
equation 4.2. The results from the 4 filters can be seen in figures 20, 21, and 22 below.

38

Figure 20: Plant-model mismatch: insulin sensitivity, glucose concentration vs. time

Figure 21: Plant-model mismatch: insulin sensitivity, effect of active insulin vs. time
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Figure 22: Plant-model mismatch: insulin sensitivity, insulin concentration vs. time

The results of the filters are summarized in table VII below. The ensemble Kalman filter
had the lowest RMSE.

CPU time (s)
RMSE: Glucose (mg/dL)
RMSE: Insulin (micro U/mL)

EKF
UKF
EnKF
PF
0.0227
5.9297
127.2572 102.7042
7.372
4.8735
3.7011
4.2731
12.7049
2.6171
2.2833
2.6021

RMSE: Effect of Active Insulin
(1/min)
3.50E-03
1.90E-03
1.90E-03 2.00E-03
Table VII: Plant-model mismatch, insulin sensitivity

The case of plant-model mismatch was then studied for the case where the true
system was that of an elderly patient while the parameter values from the estimator were
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still based off of the values from the reference [11]. A summary of the parameters for the
elderly patient are shown in the table below.
SG (min-1)

0.01572

SI min-1(microU/mL)-1

3.10E-04

k1 (min-1)

0.3606

k3 (min-1)

0.01301

Gamma min-2(microU/mL)(mg/dL)-1

0.001785

Gb (mg/dL)
105.5
Ib (microU/dL)
7.3
Table VIII: Elderly patient minimal model parameters
The goal of this case study was to see how using completely different model parameters
effects the performance of the filters. The results from the 4 filters can be seen in figures
23, 24, and 25 below.

Figure 23: Plant-model mismatch: elderly patient, glucose concentration vs. time
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Figure 24: Plant-model mismatch: elderly patient, effect of active insulin vs. time

Figure 25: Plant-model mismatch: elderly patient, insulin concentration vs. time
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The results of the filters are summarized in table IX below. The extended Kalman filter
had the lowest RMSE but none of the filters were actually able to converge to the true
state for glucose concentration, insulin concentration, or effect of active insulin.

EnKF
128.5475
37.6606
10.3877

PF
101.5256
40.7346
10.4799

RMSE: Effect of Active Insulin
(1/min)
4.20E-03 4.20E-03
4.40E-03
Table IX: Plant-model mismatch, elderly patient

4.20E-03

CPU time (s)
RMSE: Glucose (mg/dL)
RMSE: Insulin (micro U/mL)

4.4

EKF
0.0206
34.2906
9.2112

UKF
5.7411
41.706
10.6548

Increased Measurement Noise

The accuracy of glucose monitors varies across manufacturers due to the design
and sampling method that is utilized for the monitor. The current FDA standard for
glucose monitors available on the consumer market requires the monitor to be within +/15% of a reference measurement throughout the range of the monitor [22]. As a result,
the filters were compared using the initial estimate and covariance from the case of good
filter initialization and high confidence using (equation 4.2) but with an increased
measurement noise of 10 mg/dL and 15 mg/dL. In the case of a measurement noise of 10
mg/dL, the results from the 4 filters can be seen in figures 26, 27, and 28 below.
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Figure 26: Increased measurement noise: 10 mg/dL, glucose concentration vs. time

Figure 27: Increased measurement noise: 10 mg/dL, effect of active insulin vs. time
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Figure 28: Increased measurement noise: 10 mg/dL, insulin concentration vs. time
The results of the filters are summarized in table X below. The unscented Kalman filter
had the lowest RMSE. In general, there was a negligible difference in the RMSE between
the cases of measurement noise of 10 mg/dL and 5 mg/dL from section 4.1.

CPU time (s)
RMSE: Glucose (mg/dL)
RMSE: Insulin (micro U/mL)

EKF
UKF
EnKF
PF
0.0191
6.0214
121.6147 101.1347
3.1281
0.5285
1.3434
1.1003
12.1693
0.3903
0.3912
0.6676

RMSE: Effect of Active Insulin
(1/min)
1.30E-03
5.62E-05
9.89E-05 3.27E-04
Table X: Measurement noise 10 mg/dL

The case study was then conducted using the same initial estimate and covariance from
equation 4.2. In the case of a measurement noise of 15 mg/dL, the results from the 4
filters can be seen in figures 29, 30, and 31 below.
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Figure 29: Increased measurement noise: 15 mg/dL, glucose concentration vs. time

Figure 30: Increased measurement noise: 15 mg/dL, effect of active insulin vs. time
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Figure 31: Increased measurement noise: 15 mg/dL, insulin concentration vs. time
The results of the filters are summarized in table XI below. The unscented Kalman filter
had the lowest RMSE. In general, there was a negligible difference in the RMSE between
the cases of measurement noise of 15 mg/dL and 10 mg/dL.

CPU time (s)
RMSE: Glucose (mg/dL)
RMSE: Insulin (micro U/mL)

EKF
UKF
EnKF
PF
0.0183
6.0064
122.9872 98.0083
3.2576
0.498
1.2318
1.0833
12.2939
0.2752
0.3786
0.6673

RMSE: Effect of Active Insulin
(1/min)
1.30E-03
4.41E-05
9.41E-05 3.27E-04
Table XI: Measurement noise 15 mg/dL

4.5

Multiple Glucose Ingestions
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Since eating schedules may be irregular at times, this case study compared the
performance of the filters if a 2nd ingestion of approximately half of the original amount
of glucose occurs 60 minutes after the original ingestion. This was done in the simulation
by defining the glucose concentration at 60 minutes as 140 mg/dL while leaving the
insulin concentration and effect of active insulin unchanged. This allows for a more
realistic response by the system after the sudden introduction of glucose. This could
represent the patient eating a snack an hour after a regular meal. The performance of the
filters was first compared for the scenario where the filters did not know about the second
glucose ingestion. The initial state estimate and covariance were the same as equation
4.2. The results from the 4 filters can be seen in figures 32, 33, and 34.

Figure 32: Multiple glucose ingestions, filter does not know, glucose concentration vs. time
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Figure 33: Multiple glucose ingestions, filter does not know, effect of active insulin vs. time

Figure 34: Multiple glucose ingestions, filter does not know, insulin concentration
vs. time
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The results of the filters are summarized in table XII below. The particle filter had the
lowest RMSE. As seen in the figures above, the particle filter was the only filter that was
able to respond to the 2nd ingestion of glucose.

CPU time (s)
RMSE: Glucose (mg/dL)
RMSE: Insulin (micro U/mL)

EKF
UKF
EnKF
PF
0.020313
6.0273 103.683 103.9756
14.01532
13.6922 13.7116
8.3992
16.20965
10.4184 10.3612
5.7244

RMSE: Effect of Active Insulin
(1/min)
3.02E-03
2.60E-03 2.60E-03 2.10E-03
Table XII: Multiple glucose ingestions, filter does not know

The scenario of multiple glucose ingestions was then studied where the filters do
know a second glucose ingestion has occurred, this could be done in practice by having
the patient specify to the process controller that they have eaten a meal. The importance
of this is due to the equation for the change in insulin concentration being an explicit
function of time since the glucose ingestion or injection. The results of this case study can
be seen in figures 35, 36, and 37 below.
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Figure 35: Multiple glucose ingestions, filter knows, glucose concentration vs. time

Figure 36: Multiple glucose ingestions, filter knows, effect of active insulin vs. time
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Figure 37: Multiple glucose ingestions, filter knows, insulin concentration vs. time

The results of the filters are summarized in table XIII below. The unscented Kalman filter
had the lowest RMSE. In this scenario, all 4 of the filters were able to effectively respond
to the 2nd glucose ingestion and eventually converge to the true state.

CPU time (s)
RMSE: Glucose (mg/dL)
RMSE: Insulin (micro U/mL)

EKF
UKF
0.020781 6.595625
4.964501 0.9659688
12.26026 1.1124967

EnKF
PF
118.0676563 99.1173
2.597856583
3.1916
1.142380911
1.9218

RMSE: Effect of Active Insulin
(1/min)
1.29E-03
1.39E-04
1.65E-04 7.98E-04
Table XIII: Multiple glucose ingestions, filter knows
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CHAPTER V
CONCLUSION AND FUTURE WORK

Robust control of glucose and insulin levels is essential for diabetics to live
healthy normal lives. The current technology that is used to control the glucose
concentration does not take into account the dynamics of the glucose and insulin system
but rather keeps the concentrations within a range that does not result in serious medical
emergencies. The current treatment of diabetes is to inject insulin with syringes or insulin
pumps in order to compensate for the impaired glucose tolerance of the patient. The
dosages are increased or decreased by measuring the glucose concentration. The design
of future insulin pumps could be coupled with continuous glucose monitors in order to
create a process controller that would function as an artificial pancreas.
The extended Kalman filter, unscented Kalman filter, ensemble Kalman filter, and
particle filter were applied to estimate the glucose concentration, insulin concentration,
and effect of active insulin in the human body. The Minimal Model created by Bergman
was used as the system model. The performance of the filters was compared to the cases
of good filter initialization, poor filter initialization, plant-model mismatch, and multiple
glucose ingestions.
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It was observed that it is feasible to estimate the glucose concentrations, insulin
concentrations, and effect of active insulin based off of only glucose measurements.
Although computational times varied between the filters and for each case study, the
computational time was low enough that the filters would be able to be implemented in
real time for a process controller. In the case of poor filter initialization, the filters
eventually did converge to the true state. As seen in the plant-model mismatch case
studies, the performance of the filters is sensitive to the estimation of the parameters
during the glucose tolerance test. Since these parameters change as patients age, the
parameters will have to be re-estimated periodically. The case study that involved
increasing the measurement noise from the glucose measurement had a negligible effect
on the performance of the filters. As evidenced by the performance of the filters in the
case study involving multiple glucose ingestions, the actual occurrence of a meal may
have to be specified to the process controller depending on the choice of filter as only the
particle filter was able to respond to the ingestion without having access to a system
equation describing it.

Future Work

The variants of the system model that was used for this study could be
investigated for similar case studies to see if they yield better results. Increasing the
complexity may result in an increased burden on the state estimators but may result in
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better filtering of the data. In the future, other Kalman based or Monte Carlo based filters
could be applied to the problem. Once the state estimation problem of the glucose and
insulin system is solved, the next stage of the research will be the actual design and
implementation of a potential process controller.
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APPENDIX

Extended Kalman Filter
%EKF_MM
clc
clear
global k
%Initial state
x = [287;0;404];
n = length(x);
m = 1;
%Number of time steps
N = 180;
t = [1:N];
%Noise covariances
Q = 0.0001^2*eye(n);
R = sqrt(5)^2*eye(m);
%Handles for Models and Jacobian functions
f_func = @glucose_f1;
df_func = @glucose_df1_dx;
h_func = @glucose_h;
dh_func = @glucose_dh_dx;
fe_func = @glucose_f1;
dfe_func = @glucose_df1_dx;
for j=1:1
EKF_cputime=cputime;
%Storage
X = zeros(n,N);
%Generate states
X(:,1) = feval(f_func,x)+(diag(Q).^0.5).*randn(size(x));
for k = 2:N
X(:,k) = feval(f_func,X(:,k-1))+(diag(Q).^0.5).*randn(size(x));
end
Y = feval(h_func,X);
Y = Y+diag(R).^0.5.*randn(size(Y));
%Filter initialization
xf = [289;1e-7;406]; %good filter initialization
%xf = [385;1.333e-7;541]; %bad filter initialization
Pf = [4 0 0;0 1e-9 0;0 0 4]; %high confidence
%Pf = [40 0 0;0 1e-8 0;0 0 40]; %low confidence
%Pf = 0.5^2*eye(n);
%Storage;
Xf = zeros(size(X));
%Filter loop
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for k=1:N
F = feval(dfe_func,xf); %will be different than system during
plant model mismatch dfe_func and fe_func
xf = feval(fe_func,xf);
Pf = F*Pf*F'+Q;
H = feval(dh_func,xf);
K = Pf*H'*inv(H*Pf*H'+R);
xf = xf+K*(Y(:,k)-feval(h_func,xf));
Pf = Pf-K*H*Pf;
Xf(:,k) = xf;
Kh(:,k)=K;
end
EKF_cputime=cputime-EKF_cputime
comptime(j,:)=EKF_cputime;
%Mean Squared Error
Eg=sqrt(sum((1/k)*(X(1,1:k)-Xf(1,1:k)).^2));
Ex=sqrt(sum((1/k)*(X(2,1:k)-Xf(2,1:k)).^2));
Ei=sqrt(sum((1/k)*(X(3,1:k)-Xf(3,1:k)).^2));
Error(j,:)=[Eg Ex Ei]
end
Avg_Error=mean(Error)
Avg_CPU=mean(comptime)
%MSE = sum(sum((X-Xf).^2))/(n*N);
figure(1)
plot(t,X(1,:),t,Y(1,:),t,Xf(1,:),'--g')
xlabel('time [minutes]');
ylabel('Blood glucose concentration [mg/dL]');
legend('Actual Glucose Level','Measured Glucose Level','EKF
Estimated Glucose Level');
figure(2)
plot(t,X(2,:),t,Xf(2,:),'--g')
xlabel('time [minutes]');
ylabel('Effect of active insulin [1/min]');
legend('Actual Effect of Active Insulin','EKF Estimated Effect of
Active Insulin');
figure(3)
plot(t,X(3,:),t,Xf(3,:),'--g')
axis([0,180,-10,400])
xlabel('time [minutes]');
ylabel('Blood insulin concentration [micro U/mL]');
legend('Actual Insulin Level','EKF Estimated Insulin Level');

Function file for EKF: System function
%glucose_f1
function x_out = glucose_f1(x)
global t k
%parameters
SG = 0.03082; %[1/min] glucose effectiveness
SI = 5.07e-4; %[mL/uU*min] insulin sensitivity (affects frequency of
oscillation)
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k1 = 0.3; %[1/min] decay rate of blood insulin
k3 = 0.02093; %[1/min]
Gamma = 0.003349; %[1/min^2]
Ib = 7.3; % [mU/L] basal blood insulin concentration
Gb = 89.5; % [mg/dL] basal blood glucose concentration
dt = 1;
x_out(1,:) = x(1)+dt*(SG*(Gb-x(1))-x(2)*x(1));
x_out(2,:) = x(2)+dt*(k3*(SI*(x(3)-Ib)-x(2)));
x_out(3,:) = x(3)+dt*((Gamma*k*(x(1)-Gb))-(k1*(x(3)-Ib)));

Function file for EKF: System Jacobian
%glucose_df_dx
function F = glucose_df1_dx(x)
global k t
%parameters

SG = 0.03082; %[1/min] glucose effectiveness
SI = 5.07e-4; %[mL/uU*min] insulin sensitivity (affects frequency of
oscillation)
k1 = 0.3; %[1/min] decay rate of blood insulin
k3 = 0.02093; %[1/min]
Gamma = 0.003349; %[1/min^2]
Ib = 7.3; % [mU/L] basal blood insulin concentration
Gb = 89.5; % [mg/dL] basal blood glucose concentration
dt = 1;
F=[1+dt*(-SG-x(2)),dt*-x(1),0;0,1-dt*k3,dt*k3*SI;dt*Gamma*k,0,1-dt*k1];

Function file for EKF: Measurement function
%glucose_h
function y = glucose_h(x)
y = x(1,:);
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Function file for EKF: Measurement Jacobian
%glucose_dh_dx
function H = glucose_dh_dx(x)
H=[1 0 0];

Function file: Minimal Model
%minimod_v86

function dydt = minimod_v86(t,y)
global G I X Param
% dydt = zeros(size(y));
G = y(1); %[mg/dL] Glucose level
X = y(2); %[1/min] Effect of Active Insulin
I = y(3); %[uU/mL] Insulin level
%Parameters from Bergman 1986
SG = 0.03082;%0.03082; %[1/min] glucose effectiveness 2.6e-2
SI = 5.07e-4;%1.2e-4; %[mL/uU*min] insulin sensitivity (affects
frequency of oscillation)
k1 = 0.3;%0.3; %[1/min] decay rate of blood insulin 0.27
k3 = 0.02093;%0.02093; %[1/min] 0.025
Gamma = 0.003349;%0.003349; %[1/min^2] 0.0041
Ib = 7.3; % [microU/mL] basal blood insulin concentration
Gb = 89.5; % [mg/dL] basal blood glucose concentration
Param = [SG SI k1 k3 Gamma];
dGdt
dXdt
dIdt
dydt
end

=
=
=
=

SG*(Gb-G)-X*G;
k3*(SI*(I-Ib)-X);
(Gamma*(G-Gb)*t)-(k1*(I-Ib));
[dGdt; dXdt; dIdt];

Unscented Kalman Filter
%minimalmodel_v18_UKF.m
%original Bergman minimal model for blood glucose
clc
clear
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global G I X Gm t
Q=0.0001^2;%*eye(3);
R=5; %measurement noise covaraiance
for t=1:180
s=1; %sampling interval (minutes)
%Solve ODE
tspan = [0:t];
y0 = [287; 0; 404];
[t,y] = ode15s('minimod_v86', tspan, y0);
G=y(:,1);
X=y(:,2);
I=y(:,3);
%disp([t,G,X,I]);
L=length(tspan);
%next time step initial conditions
y0=[G; X; I];
end

xt=[G X I];
Gm=G+sqrt(R)*randn(L,1);
yt=[Gm];

figure(1)
plot(t,G,t,Gm,'-r');
xlabel('time [minutes]');
ylabel('Blood glucose concentration [mg/dL]');
legend('Actual Glucose Level','Measured Glucose Level');

figure(2)
plot(t,X);
xlabel('time [minutes]');
ylabel('Effect of active insulin [1/min]');
legend('Actual Effect of Active Insulin');
figure(3)
plot(t,I);
xlabel('time [minutes]');
ylabel('Blood insulin concentration [microU/mL]');
legend('Actual Insulin Level');
axis([0,180,-4,400])
%apply Unscented Kalman Filter
%Unscented Kalman Filter
%generate weights for mean
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n=3; %number of states
N=7; %number of sigma points
alpha=0.8; %usually 0.5
beta=2; %usually 2
kappa=3-n; %usually 3-n
lambda=alpha^2*(n+kappa)-n;
Wa0=lambda/(n+lambda);
Wc0=lambda/(n+lambda)+1-alpha^2+beta;
Wai=1/(2*(n+lambda));
Wci=1/(2*(n+lambda));
Wa=[repmat(Wai,3,1); Wa0; repmat(Wai,3,1)];
matrix
Wc=[repmat(Wci,3,1); Wc0; repmat(Wci,3,1)];
7x1matrix
Wad=diag(Wa);
Wcd=diag(Wc);

%weighted average 7x1
%weighted covariance

%100 realizations
for m=1:100 %change to 100 when ready
% xt=xt+randn(size(xt))*(sqrt(Q));
UKF_cputime=cputime;
%initial condition at t=0 or k=0
%generate initial sigma points (need 7)
Gavg=289*ones(1,7);
Xavg=1e-7*ones(1,7);
Iavg=406*ones(1,7);
sigma_points=[Gavg; Xavg; Iavg];
P=[4 0 0; 0 1e-9 0; 0 0 4]; %initial covariance matrix Pxx High
Confidence
%P=[40 0 0; 0 1e-8 0; 0 0 40]; %initial covariance matrix Pxx Low
Confidence
%Psqrt=chol(P)+chol(P)'-diag(diag(chol(P)))
Psqrt=sqrtm(P)
Pmat=[-Psqrt zeros(3,1) Psqrt]
sigma_points=sigma_points+Pmat;
Xhat=zeros(length(t),3); %pre-allocate space for estimate
Xhat(1,:)=sigma_points(:,4); %store initial state estimate
x=zeros(3,7);
for rt=1:length(t)-1
%Solve ODE for each set of sigma points
tspan = [rt-1:rt];
for j=1:7
ic(j,:)=[sigma_points(:,j)];
[te,y] = ode15s('minimod_v86', tspan, ic(j,:));
x(:,j)=[y(end,1); y(end,2); y(end,3)];
end
disp(x) %3x7 matrix
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%generate new sigma points based on new mean and covariance
%compute weighted mean
xhat=x*Wa; %3x7 x 7x1 = 3x1 matrix
sigma_points=[xhat(1)*ones(1,7);
xhat(2)*ones(1,7);xhat(3)*ones(1,7)];
%compute covariance
diff_co=x-sigma_points; %3x7 matrix
P=diff_co*Wcd*diff_co'; %updated covariance matrix Pxx
%Psqrt=chol(P)+chol(P)'-diag(diag(chol(P)))
Psqrt=(sqrtm(P))
Pmat=[-Psqrt zeros(3,1) Psqrt]
sigma_points=sigma_points+Pmat;
x=sigma_points
% pause
%try to update P
xhat=x*Wa; %3x7 x 7x1 = 3x1 matrix
sigma_points=[xhat(1)*ones(1,7);
xhat(2)*ones(1,7);xhat(3)*ones(1,7)];
%compute covariance
diff_co=x-sigma_points; %3x7 matrix
%generate "fake" or "predictive" measurements
Per=[sqrt(R)^2 sqrt(R)^2 sqrt(R)^2];
Per=diag(Per);
%Persqrt=chol(Per)+chol(Per)'-diag(diag(chol(Per)))
Persqrt=sqrtm(Per)
Persqrt=diag(Persqrt)
Pmater=[-Persqrt; 0; Persqrt]'
y=x(1,:)+Pmater
ynew=yt(rt+1)*ones(size(y))
diff=ynew-y
%pause
%Kalman Gain
xhatv=x*Wa; %weighted average of state sigma points
yhatv=y*Wa; %weighted average of "fake" measurements
Pyy=diff*Wcd*diff'+R; %measurement variance
this R
Pxy=diff_co*Wcd*diff'; %updated covariance matrix
K= Pxy*inv(Pyy)
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maybe delete

sumk=K*diff
x=x+sumk

%Apply UKF to state

%compute weighted average for estimate
xhat=x*Wa;
%generate new sigma points for next time step
sigma_points=[xhat(1)*ones(1,7);
xhat(2)*ones(1,7);xhat(3)*ones(1,7)];
%compute covariance
diff_co=x-sigma_points;
P=diff_co*Wcd*diff_co'; %updated covariance matrix
% Psqrt=chol(P)+chol(P)'-diag(diag(chol(P)))
Psqrt=(sqrtm(P));
Pmat=[-Psqrt zeros(3,1) Psqrt];
%initial conditions for net time step
sigma_points=sigma_points+Pmat

%Storage
Xhat(rt+1,1)=xhat(1);
Xhat(rt+1,2)=xhat(2);
Xhat(rt+1,3)=xhat(3);
Khat(rt,:)=K;
diffhat(rt,:)=diff;
Pxyhat(rt,:)=Pxy;
Pyyhat(rt,:)=Pyy;
diff_cohat(rt,1)=diff_co(1);
diff_cohat(rt,2)=diff_co(2);
diff_cohat(rt,3)=diff_co(3);
end
UKF_cputime=cputime-UKF_cputime
disp(Xhat)
%add filter estimate to figures
figure(4)
plot(t,xt(:,1),'-b',t,Gm,'-r', t,Xhat(:,1),'--g');
xlabel('time [minutes]');
ylabel('Blood glucose concentration [mg/dL]');
legend('Actual Glucose Level','Measured Glucose Level','UKF
Estimated Glucose Level');

figure(5)
plot(t,xt(:,2),'-b', t, Xhat(:,2), '--g');
xlabel('time [minutes]');
ylabel('Effect of active insulin [1/min]');
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legend('Actual Effect of Active Insulin','UKF Estimated Effect of
Active Insulin');
figure(6)
plot(t,xt(:,3),'-b', t, Xhat(:,3),'--g');
axis([0,180,-5,400])
xlabel('time [minutes]');
ylabel('Blood insulin concentration [micro U/mL]');
legend('Actual Insulin Level','UKF Estimated Insulin Level');
%Mean Squared Error
Eg=sqrt(sum((1/rt)*(xt(1:rt+1,1)-Xhat(1:rt+1,1)).^2));
Ex=sqrt(sum((1/rt)*(xt(1:rt+1,2)-Xhat(1:rt+1,2)).^2));
Ei=sqrt(sum((1/rt)*(xt(1:rt+1,3)-Xhat(1:rt+1,3)).^2));
Error(m,:)=[Eg Ex Ei]
comptime(m,:)=UKF_cputime;
end
Avg_Error=mean(Error)
Avg_CPU=mean(comptime)

Ensemble Kalman Filter
%minimalmodel_v14EnKF.m
%original Bergman minimal model for blood glucose
clc
clear
global G I X Gm t
R = 5; %measurement covariance
%Process Simulation
for t=1:180
s=1; %sampling interval (minutes)
%Solve ODE
tspan = [0:t];
y0 = [287; 0; 404];
[t,y] = ode15s('minimod_v86', tspan, y0);
G=y(:,1);
X=y(:,2);
I=y(:,3);
%disp([t,G,X,I]);
L=length(tspan);
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%next time step initial conditions
y0=[G; X; I];
end
Gm=G+sqrt(R)*randn(L,1); %glucose measurement
xt=[G X I];
yt=[Gm];

figure(1)
plot(t,G, t,Gm,'-r');
xlabel('time [minutes]');
ylabel('Blood glucose concentration [mg/dL]');
legend('Actual Glucose Level','Measured Glucose Level');

figure(2)
plot(t,X);
xlabel('time [minutes]');
ylabel('Effect of active insulin [1/min]');
legend('Actual Effect of Active Insulin');
figure(3)
plot(t,I);
xlabel('time [minutes]');
ylabel('Blood insulin concentration [mU/L]');
legend('Actual Insulin Level');

%apply Ensemble Kalman Filter
%Ensemble Kalman Filter
%use 100 realizations
for n=1:1 %change to 100 when ready
EnKF_cputime=cputime;
%initial condition at t=0 or k=0
Nsamples=100;
%use 100 random possibilities of true state
at t=0
GEnKF=289+sqrt(4)*randn(Nsamples,1);
XEnKF=(1e-7+sqrt(1e-9)*randn(Nsamples,1));
IEnKF=406+sqrt(4)*randn(Nsamples,1);
x=[GEnKF XEnKF IEnKF];
%initial conditions: Nsamples X 3 Matrix
Xhat=zeros(length(t),3); %pre-allocate space for estimation matrix
Xhat(1,:)=[289 1e-7 406];
%dynamics

for rt=1:length(t)-1
k=length(rt);
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%Solve ODE
for j=1:length(x)
ic=x(j,:);

%pass each point through ode

tspan = [rt-1:rt];
[te,y] = ode15s('minimod_v86', tspan, ic);
x(j,:)=[y(end,1),y(end,2),y(end,3)];
disp(x);
L=length(tspan);
%Storage
end
y=x(:,1)+sqrt(R)*randn(length(x(:,1)),1);
ynew=yt(rt)*ones(size(y));
diff=ynew-y;

%Kalman Gain
xhatv=mean(x);
yhatv=mean(y); %average of "fake" measurements

Pyy=var(y)+R;
Gcov=cov(x(:,1),y);
Xcov=cov(x(:,2),y);
Icov=cov(x(:,3),y);
Pgy=Gcov(1,2);
Pxy=Xcov(1,2);
Piy=Icov(1,2);
PXy=[Pgy; Pxy; Piy];

%

K= PXy*(Pyy.^-1);
K= Pxy*inv(Pyy)
sumk=diff*K';
x=x+sumk;

%Apply EnKF to state

%compute average for estimate
xhat=mean(x);

%Storage
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Xhat(rt+1,1)=xhat(1);
Xhat(rt+1,2)=xhat(2);
Xhat(rt+1,3)=xhat(3);
Khat(rt,:)=K;
Pyyhat(rt,:)=Pyy;
PXyhat(rt,:)=PXy;
diffhat(rt,:)=diff;

end
EnKF_cputime=cputime-EnKF_cputime
%add filter estimate to figures
figure(4)
plot(t,xt(:,1),'-b',t,Gm,'-r', t,Xhat(:,1),'--g');
xlabel('time [minutes]');
ylabel('Blood glucose concentration [mg/dL]');
legend('Actual Glucose Level','Measured Glucose Level','EnKF
Estimated Glucose Level');

figure(5)
plot(t,xt(:,2),'-b', t, Xhat(:,2), '--g');
xlabel('time [minutes]');
ylabel('Effect of active insulin [1/min]');
legend('Actual Effect of Active Insulin','EnKF Estimated Effect of
Active Insulin');
figure(6)
plot(t,xt(:,3),'-b', t, Xhat(:,3),'--g');
axis([0,180,-5,400])
xlabel('time [minutes]');
ylabel('Blood insulin concentration [micro U/mL]');
legend('Actual Insulin Level','EnKF Estimated Insulin Level');
%Mean Squared Error
Eg=sqrt(sum((1/rt)*(xt(1:rt+1,1)-Xhat(1:rt+1,1)).^2));
Ex=sqrt(sum((1/rt)*(xt(1:rt+1,2)-Xhat(1:rt+1,2)).^2));
Ei=sqrt(sum((1/rt)*(xt(1:rt+1,3)-Xhat(1:rt+1,3)).^2));
% format long
Error(n,:)=[Eg Ex Ei]
comptime(n,:)=EnKF_cputime;
end
Avg_Error=mean(Error)
Avg_CPU=mean(comptime)
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Function file: Resample
function Y = resampleX_test(X,alpha,r)
%
% By: Ron Abileah, Vista Research Inc
%
% Original version: November 10, 2005
% Version 1.1
December 1, 2005
%
- Corrected comments and mentioned similarity
to
%
MATLAB function "resample."
%
- Output Y is row (column) if input X is row
%
(column)
%
- Sets alpha to default value (1) if alpha is
not provided
% Version 1.2
December 15, 2005
%
- Corrected indexing bug discovered by Eike
%
Rietsch. This improved accuracy.
% Version 1.3
October 23, 2006
%
- Corrected bug in handling the value at
Nyquist,
%
which caused a slight increase in
interpolation
%
error. The problem was pointed out by a user
who
%
found that resampleX(x,1) did not return
exactly
%
x.
%
% Resamples X(n). Y(n) = X(alpha*n), where alpha is a resample
interval.
% For example, if X is data sampled at 1000 samples per second and you
% would like to transform it to the equivalent of 1100 samples per
second
% use alpha= 1000/1100 (.9091); for 800 sample per second
% use alpha = 1000/800 (1.25).
%
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% ResampleX is similar to the MATLAB "resample" function (in the
Signal
% Processcing Toolbox). There are two differences:
%
% (1) The MATLAB resample does some fancy schmancy interpolation of
the
%
original time series; resampleX works on the Fourier trasnform
of
%
the time series. The main benefit of FT processing is speed.
% (2) MATLAB resample cputime depends on the value of alpha. It runs
faster with
%
simple rational numbers. The cputime of resampleX is
indpendent of
%
alpha.
%
% The main reason for using resampleX instead of resample is speed.
In
% test cases resampleX was generaly 5-20 times faster.
Use resample
if
% your alpha values are simple rational numbers or numerical accuracy
is more
% important. Use resampleX for very general values of alpha or where
some
% accuracy can be traded for speed.
%
% ResampleX uses the fact that resampling a time series X by a factor
alpha is
% equivalent to resampling the frequency samples of its transform by
m/alpha,
% where m is a frequency index.
%
% The calling sequence is one of the following
%
%
Y = resampleX(X,alpha)
%
Y = resampleX(X,alpha,r)
%
Y = resampleX
%
% X can be real or complex. Output Y is the same length as X.
% If alpha > 1 some Y's will be extrapolations beyond the end of X.
% Extrapolated values are not realiable, so throw them away. Keep
only
% the first N/alpha values, where N is the original length of the
data.
% Whne X is real, Y's may have small imaginary values due to
% approximations.
%
% Optional parameter r is an integer frequency interpolation factor.
The
% function will work with r = 1, but r = 2,4, or more produces more
% accurate results. Use r=64 if you want very accurate results and
are
% not too concerned about computing time. The default value is r = 8.
%
% Calling the function with no arguments produces a test signal and a
plot
% of the original and resampled signal with alpha =0.95, r = 8.
%
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% -- Set r to its default value if not specified as input argument
if ~exist('r')
r = 8; end
% -- Produce test signal if there are no input arguments
if nargin == 0
x1=0:pi/64:2*pi;
X=exp(i*x1)+0.5*exp(i*3*x1)+0.25*exp(i*x1.^2);
alpha = 0.95;
end
% The default value of alpha is 1
if nargin == 1
alpha =1;
end
% -- zero pad X for frequency interpolation
Y=X;
N0=length(Y); N=r*N0; N2 = N/2;
if r >1
Y(N)=0;
end
% -- Fourier transform the padded time series
Y = fft(Y);
n = 1:length(X);
% -- Resample the Fourier transform
m = round((0:(N2-1))./alpha) - (0:(N2-1));
f = floor(alpha.*N2); m((f+1):end)=NaN;
m = [ m 0 -fliplr(m(2:end)) ] + (1:N) ;
m(find(isnan(m)))=N2+1;
Y=ifft(Y(m));
Y=Y(1:N0)/alpha;

if nargin>0
return
end
% -- Display results
figure
n=1:N0;
plot( n ,real(X),'-k' ,n ,imag(X),'--k',...
n ,real(Y),'-r' ,n ,imag(Y),'--r')
xlabel('Sample number'); ylabel('Amplitude')
axis([1 N0 -2 2])
legend ('Original real', 'Original imaginary ', 'Resampled
real','Resampled imaginary')
end
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Particle Filter
%minimalmodel_v1PF.m
%original Bergman minimal model for blood glucose
clc
clear
global G I X Gm t
R=5; %measurement noise variance (mg/dL)
%Process Simulation
for t=1:180
s=1; %sampling interval (minutes)
%Solve ODE
tspan = [0:t];
y0 = [287; 0; 404];
[t,y] = ode45('minimod_v86', tspan, y0);
G=y(:,1);
X=y(:,2);
I=y(:,3);
%disp([t,G,X,I]);
L=length(tspan);
%next time step initial conditions
y0=[G; X; I];
end
Gm=G+sqrt(R)*randn(L,1);
xt=[G X I];
yt=[Gm];

figure(1)
plot(t,G, t,Gm,'-r');
xlabel('time [minutes]');
ylabel('Blood glucose concentration [mg/dL]');
legend('Actual Glucose Level','Measured Glucose Level');

figure(2)
plot(t,X);
xlabel('time [minutes]');
ylabel('Effect of active insulin [1/min]');
legend('Actual Effect of Active Insulin');
figure(3)
plot(t,I);
xlabel('time [minutes]');
ylabel('Blood insulin concentration [mU/L]');
legend('Actual Insulin Level');
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%apply Gordon Salmond and Smith Particle Filter
%Particle Filter
%use 100 realizations
for n=1:1 %change to 100 when ready
PF_cputime=cputime;
%initial condition at t=0 or k=0
Nsamples=100;
%use 100 random possibilities of true state
at t=0
GEnKF=289+sqrt(4)*randn(Nsamples,1);
XEnKF=(1e-7+sqrt(1e-9)*randn(Nsamples,1));
IEnKF=406+sqrt(4)*randn(Nsamples,1);
x=[GEnKF XEnKF IEnKF];
%initial conditions: Nsamples X 3 Matrix
Xhat=zeros(length(t),3);
Xhat(1,:)=[289 1e-7 406];
%dynamics

for rt=1:length(t)-1
% k=length(rt);

%Solve ODE
for j=1:length(x)
ic=x(j,:);

%pass each point through ode

tspan = [rt-1:rt];
[te,y] = ode15s('minimod_v86', tspan, ic);
Gen=y(end,1);
Xen=y(end,2);
Ien=y(end,3);
x(j,:)=[Gen,Xen,Ien];
disp([Gen,Xen,Ien]);
L=length(tspan);
%Storage
end
%pause
y=x(:,1)+sqrt(R)*randn(length(x(:,1)),1);
ynew=yt(rt)*ones(size(y));
diff=ynew-y;
%compute weight of particles (using Gaussian PDF)
w=(1/sqrt(2*pi*R))*exp((-1*(diff).^1.8)/(2*R)); %was 1.8
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%normalize weight
w=w/sum(w);
w=[w w w];
%weighted average
xhat=sum(x.*w);
%Storage
Xhat(rt+1,1)=xhat(1);
Xhat(rt+1,2)=xhat(2);
Xhat(rt+1,3)=xhat(3);

%Resample
x(:,1)=resampleX(x(:,1),0.9995); %was 0.35
x(:,2)=resampleX(x(:,2),0.9995);
x(:,3)=resampleX(x(:,3),0.9995);
end
PF_cputime=cputime-PF_cputime
%add filter estimate to figures
figure(4)
plot(t,xt(:,1),'-b',t,Gm,'-r', t,Xhat(:,1),'--g');
xlabel('time [minutes]');
ylabel('Blood glucose concentration [mg/dL]');
legend('Actual Glucose Level','Measured Glucose Level','PF
Estimated Glucose Level');

figure(5)
plot(t,xt(:,2),'-b', t, Xhat(:,2), '--g');
xlabel('time [minutes]');
ylabel('Effect of active insulin [1/min]');
legend('Actual Effect of Active Insulin','PF Estimated Effect of
Active Insulin');
figure(6)
plot(t,xt(:,3),'-b', t, Xhat(:,3),'--g');
axis([0,180,-5,400])
xlabel('time [minutes]');
ylabel('Blood insulin concentration [micro U/mL]');
legend('Actual Insulin Level','PF Estimated Insulin Level');
%Mean Squared Error
Eg=sqrt(sum((1/rt)*(xt(1:rt+1,1)-Xhat(1:rt+1,1)).^2));
Ex=sqrt(sum((1/rt)*(xt(1:rt+1,2)-Xhat(1:rt+1,2)).^2));
Ei=sqrt(sum((1/rt)*(xt(1:rt+1,3)-Xhat(1:rt+1,3)).^2));
Error(n,:)=[Eg Ex Ei]
comptime(n,:)=PF_cputime;
end
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Avg_Error=mean(Error)
Avg_CPU=mean(comptime)
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